Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Iloperidone	295
Overall Study	STARTED	Ziprasidone	149
Overall Study	STARTED	Placebo	149
Overall Study	Safety Population	Iloperidone	300
Overall Study	Safety Population	Ziprasidone	150
Overall Study	Safety Population	Placebo	147
Overall Study	COMPLETED	Iloperidone	193
Overall Study	COMPLETED	Ziprasidone	98
Overall Study	COMPLETED	Placebo	90
Overall Study	NOT COMPLETED	Iloperidone	102
Overall Study	NOT COMPLETED	Ziprasidone	51
Overall Study	NOT COMPLETED	Placebo	59

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00254202/flow